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Methods

Introduction and Background
The Wnt signaling pathway has been previously shown to play a major
role in regulating bone metabolism and it is emerging as a target for the
therapeutic intervention of bone thinning disorders such as osteoporosis.
Several Wnt proteins have been shown to be expressed in bone and
mutations in Wnt pathway members such as Wnt co-receptor Lrp5 and
Wnt inhibitor Sost have been shown to be associated with low or high
bone mass disorders, however, very little is known about specific roles
played by different Wnt ligands in bone development, repair and
remodeling. To identify downstream targets of Wnt signaling we
sequence RNA synthesized by Wnt3a treated osteoblasts and found 214
genes to be significantly up-regulated by >2-fold in the presence of
Wnt3a ligand. Computational analysis of ChipSeq data in the loci of
these 214 genes predicted 163 putative Wnt-inducible enhancers. In this
project, we sought to functionally validate these putative enhancer
elements that may account for the Wnt3a-dependent activation of these
214 transcripts. Candidate enhancers were cloned, transfected into
osteoblast-like cell lines, and examined for transgene expression in the
presence and absence of recombinant Wnt3a protein. Preliminary data
suggests that several noncoding elements may have enhancer properties
both in the absence or presence of Wnt3a, in vitro.

Create enhancer-expression constructs
• Design primers and PCR amplify putative enhancers
• Clone enhancers into expression plasmids
• Identify correct inserts using restriction
enzyme digests

Determine if enhancers are Wnt inducible
•
•
•
•
•
•

Prep DNA for transfection
Grow cells for transfection while learning aseptic
tissue culture techniques
Transform UMR cells with enhancer clones
Treat transfected clones with Wnt3a
Quantify transgene expression via luciferase reporter gene
Determine if transfected clones are Wnt3a inducible

Figure 4. Topflash plasmid
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• Osteoblasts are bone cells responsible for bone formation.
• Wnt describes a family of highly conserved proteins that regulate cell
proliferation, fate specification, polarity, and migration.
• Wnt signal stimulates several intra-cellular signal transduction
cascades, including the canonical or Wnt/β-catenin dependent
pathway.
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Figure 5. Gel electrophoresis for diagnostic
digest shows positive screening results after
cloning with the appropriate enhancer inserts.
First lane shows a 1KB+ molecular weight
ladder as a reference for DNA fragment size.
Large molecular weight bands show the vector
backbone and circled bands show successful
inserts.

Figure 1. When Wnt receptor complexes
are not bound by ligands, β-catenin is
targeted for rapid destruction and
transcription of Wnt target genes is
inhibited. Once bound by Wnt, a coreceptor complex activates the canonical
signaling pathway stabilizing β-catenin
and promotes the transcription of Wnt
target genes.

Figure 6. Expression level in relative light units of reporter gene
driven by enhancer constructs in the absence of Wnt3a.
Significant increase in expression shows enhancers are active
regardless of Wnt3a activation. When compared to the
expression level of the negative control which has no TCF/LEF
binding sites, three enhancers showed significant expression
levels without added recombinant Wnt3a protein. These
enhancers include the positive control (p-value=0.0047), Errfil
(p-value=0.0131), and Fosl2-H (p-value=0.0023).

Figure 7. Expression level in relative light units of reporter gene
driven by enhancer constructs in the presence of Wnt3a.
Comparing stimulated and unstimulated expression driven by
enhancers. Increase fold change indicates enhancers are active
due to Wnt3a activation. The Topflash plasmid positive control
showed significant up-regulation of transgenic expression in the
presence of Wnt3a protein (p-value=0.0106). This is in
concurrence with its seven TCF/LEF binding sites which greatly
increase the amount of Wnt-signaling. Bhlhe40 (p-value=0.0098)
also experienced a significant increase in transgenic expression.

Conclusions and Next Steps
• Enhancers are distal regulatory elements that bind transcription factors
and increase the rate of transcription of genes.
• 20 putative enhancer regions were selected based on close proximity
to a gene up-regulated by Wnt3a administration, the presence of
TCF/LEF binding sites, DNAse hypersensitivity, as well as
methylation and acetylation markers.

Through diagnostic digests using the appropriate restriction enzymes, we were able to identify and isolate the correct inserts, properly transfect them into UMR host cells, and
quantify transgene expression through a luciferase reporter gene. Cloning enhancers into expression plasmids was successful, and the preliminary data from this experiment
showed that there was at least one enhancer that significantly up-regulated transgenic expression in the presence of Wnt3a. The Topflash plasmid positive control has seven
TCF/LEF binding sites which aided in significantly up-regulating expression in the presence of Wnt3a (p-value=0.0106). The Bhlhe40 enhancer also showed a significant
increase in transgenic expression (p-value=0.0098). To increase the reproducibility of this experiment, future studies might include plating a higher concentration of cells for
transfection and letting them transfect for a longer period of time. These validated enhancers further our understanding of transcriptional regulation by Wnt signaling, and will
be used to improve conditions for validation of more putative enhancers in the future. These findings will also be used to examine relationships between Wnt-inducible
enhancers and predicted phenotypes such as bone formation. These Wnt inducible enhancers may have additional effects in humans and may be sites for developmental control.
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